Start Date
September 30, 2000
Primary Completion Date
November 30, 2003
Study Completion Date
November 30, 2003
anti-thymocyte globulin
New York Presbyterian Hospital - Cornell Campus, New York
Mount Sinai Medical Center, NY, New York
New York Medical College, Valhalla
James P. Wilmot Cancer Center, Rochester
Washington Cancer Institute, Washington D.C.
Winship Cancer Institute of Emory University, Atlanta
Sylvester Cancer Center, University of Miami, Miami
Veterans Affairs Medical Center - Tampa (Haley), Tampa
Cleveland Clinic Taussig Cancer Center, Cleveland
Indiana Blood and Marrow Transplant, Beech Grove
Rush Cancer Institute, Chicago
Siteman Cancer Center, St Louis
University of Missouri Kansas City School of Medicine, Kansas City
Tulane University School of Medicine, New Orleans
University of Florida Health Science Center, Gainesville
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Holden Comprehensive Cancer Center, Iowa City
University of Kansas Medical Center, Kansas City
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Saint Louis University Cancer Center, St Louis
University of Nebraska Medical Center, Omaha
Hackensack University Medical Center, Hackensack
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Texas Oncology P.A., Dallas
Medical College of Wisconsin, Milwaukee
Foothills Hospital, Calgary
Department of Medicine, Vancouver
Princess Margaret Hospital, Toronto
Genzyme, a Sanofi Company
INDUSTRY